NCT06506591

A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics,Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 106 (actual)
• Sponsor: Zhejiang Wenda Pharma Technology LTD. · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This is a phase I, randomised, double-blind, placebo-controlled, 3-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of WD-890 Tablets in Healthy Chinese Subjects

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	WD-890	Administered P.O.
DRUG	WD-890 Tablets Placebo	Administered P.O.

Timeline

• Start date: 2023-10-26
• Primary completion: 2024-08-15
• Completion: 2024-08-15
• First posted: 2024-07-17
• Last updated: 2025-03-07

Locations

1 site across 1 country: China